Abbott Ups Its Ante On ADCs With Expanded Seattle Genetics Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
Abbott broadens its deal with Seattle Genetics in the hot space of antibody-drug conjugates just days after announcing a pipeline setback with another partner.